What is BMY's five-year median P/E?

18.1x. Half of BMY's weekly readings since February 2022 were higher and half were lower. This page has 862 weekly readings, from Apr 26, 2010 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares BMY only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Bristol Myers Squibb (BMY) valuation history

Health Care

$61.39

Latest weekly close · Market cap $126.0B

Below its usual range

Bristol Myers Squibb's P/E of 13.6x is lower than 85% of its weekly readings since February 2022 (as of Oct 30, 2026).

Forward P/E 9.3× (analyst estimates, not ranked).

Weekly P/E since February 2022

P/E each weekMiddle half of its readingsMedian 18.1×

Median: 18.1×
Low to high: 12.4× to 28.0×
Versus median: -25%
History starts: February 2022

P/E

15thpercentile

of its weekly readings since February 2022

Growth, last 12 months vs the year before

Revenue: +4%accelerating
EPS: +52%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

BMY P/E at each year-end
Year-end	P/E	5-year percentile
Dec 29, 2025	18.1×	40
Dec 30, 2024	n/m	Too little history
Dec 25, 2023	13.0×	8
Dec 26, 2022	23.4×	37
Dec 27, 2021	n/m	Too little history
Dec 28, 2020	n/m	Too little history
Dec 30, 2019	18.2×	17
Dec 31, 2018	53.3×	62
Dec 25, 2017	24.1×	15
Dec 26, 2016	29.2×	24

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare BMY with peers

Health Care peers of BMY on P/E
Stock	P/E	Versus its own history	5-year percentile
AXSMAxsome Therapeutics Inc	n/m	Not ranked	n/m, not ranked
CORTCorcept Therapeutics Inc	204.6×	Historically high	92
ELANElanco Animal Health Inc	n/m	Not ranked	n/m, not ranked
JAZZJazz Pharmaceuticals PLC	14.2×	Historically low	7
JNJJohnson & Johnson	41.8×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Nuclear Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on BMY

No articles about BMY yet. How valuation percentiles work

Loading peers and related research…

About this history

What is BMY's current P/E?: Bristol Myers Squibb's P/E of 13.6x is lower than 85% of its weekly readings since February 2022 (as of Oct 30, 2026).
What is BMY's five-year median P/E?: 18.1x. Half of BMY's weekly readings since February 2022 were higher and half were lower. This page has 862 weekly readings, from Apr 26, 2010 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares BMY only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.